11 Best Healthcare Penny Stocks to Buy Now

2. Taysha Gene Therapies Inc. (NASDAQ:TSHA)

Share Price: $2.92

Number of Hedge Fund Holders: 34

Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best healthcare penny stocks to buy now. On September 12, analysts at JMP Securities reiterated a ‘Market Perform’ rating on the stock and a $6 price target.

The positive stance follows the stock’s impressive 56% year-to-date gain. It also follows solid second-quarter results, whereby revenue totaled $1.98 million, exceeding analysts’ estimates of $1.82 million.

The stock’s sentiments have also received a significant boost from the development of TSHA-102 for Rett Syndrome. The gene therapy edge stems from its ability to provide consistent distribution across the brain while leveraging the AAV9 vector.

The treatment has already been administered to 12 patients, with no serious adverse events reported. The company plans to begin patient enrollment in the fourth quarter, meeting key FDA requirements.

Taysha Gene Therapies Inc. (NASDAQ:TSHA) is a clinical-stage biotechnology company that develops and commercializes gene therapies for severe monogenic diseases of the central nervous system (CNS). These therapies utilize adeno-associated virus (AAV) vectors to target diseases resulting from a single genetic mutation.